Clinical trials
Phase 2/3 Head and Neck Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 8 |
| Terminated | 6 |
| Unknown status | 4 |
| Withdrawn | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| All India Institute of Medical Sciences | 2 |
| Sanofi | 2 |
| Second Affiliated Hospital of Guangzhou Medical University | 2 |
| Ain Shams University | 1 |
| Alberta Health services | 1 |
| Bicara Therapeutics | 1 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
| Dana-Farber Cancer Institute | 1 |
| General Hospital Groeninge | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 32 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Breast Neoplasms | 3 |
| Carcinoma, Squamous Cell | 3 |
| Laryngeal Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Melanoma | 3 |
| Mouth Neoplasms | 3 |
| Neoplasms, Squamous Cell | 3 |
| Oropharyngeal Neoplasms | 3 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.